Renin–angiotensin system blockers, risk of SARS-CoV-2 infection and outcomes from CoViD-19: systematic review and meta-analysis

MMY Lee, KF Docherty, N Sattar… - European Heart …, 2022 - academic.oup.com
Aims This meta-analysis provides summary odds ratio (OR) estimates for associations
between treatment with (vs. without) renin–angiotensin system blockers and risk of severe …

Diabetes is most important cause for mortality in COVID-19 hospitalized patients: Systematic review and meta-analysis

G Corona, A Pizzocaro, W Vena, G Rastrelli… - Reviews in Endocrine …, 2021 - Springer
The presence of SARS-CoV-2 was officially documented in Europe at the end of February
2020. Despite many observations, the real impact of COVID-19 in the European Union (EU) …

Association of hypertension and antihypertensive treatment with COVID-19 mortality: a retrospective observational study

C Gao, Y Cai, K Zhang, L Zhou, Y Zhang… - European heart …, 2020 - academic.oup.com
Aims It remains unknown whether the treatment of hypertension influences the mortality of
patients diagnosed with coronavirus disease 2019 (COVID-19). Methods and results This is …

Diabetes mellitus e hipertensión arterial como factor de riesgo de mortalidad en pacientes con Covid-19

PJ Navarrete-Mejía, FA Lizaraso-Soto… - Revista del Cuerpo …, 2020 - scielo.org.pe
Resumen NAVARRETE-MEJIA, Pedro Javier; LIZARASO-SOTO, Frank Antonio; VELASCO-
GUERRERO, Juan Carlos y LORO-CHERO, Luis Melchor. Diabetes mellitus and arterial …